XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 12.68%, Johnson & Johnson at 8.63%, AbbVie at 7.85%, UnitedHealth Group at 6.20%, and Abbott Laboratories at 4.45%.

Total Holdings

Top 10 Percentage

57.03%

Asset Class

Equity

ETF Category

Health

Assets

35.59B

PE Ratio

20.73

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.68%	5,450,747
2	JNJ	Johnson & Johnson	8.63%	16,511,864
3	ABBV	AbbVie Inc.	7.85%	12,111,685
4	UNH	UnitedHealth Group Incorporated	6.20%	6,209,366
5	ABT	Abbott Laboratories	4.45%	11,932,736
6	MRK	Merck & Co., Inc.	4.23%	17,125,031
7	TMO	Thermo Fisher Scientific Inc.	3.90%	2,588,916
8	ISRG	Intuitive Surgical, Inc.	3.08%	2,457,797
9	AMGN	Amgen Inc.	3.05%	3,691,034
10	PFE	Pfizer Inc.	2.96%	38,980,659
11	BSX	Boston Scientific Corporation	2.74%	10,159,100
12	GILD	Gilead Sciences, Inc.	2.66%	8,507,138
13	DHR	Danaher Corporation	2.60%	4,369,359
14	SYK	Stryker Corporation	2.42%	2,359,079
15	MDT	Medtronic plc	2.38%	8,784,412
16	VRTX	Vertex Pharmaceuticals Incorporated	1.96%	1,757,852
17	CVS	CVS Health Corporation	1.87%	8,695,790
18	BMY	Bristol-Myers Squibb Company	1.76%	13,955,098
19	MCK	McKesson Corporation	1.74%	852,709
20	CI	The Cigna Group	1.58%	1,830,111
21	ELV	Elevance Health, Inc.	1.50%	1,543,831
22	HCA	HCA Healthcare, Inc.	1.34%	1,123,013
23	ZTS	Zoetis Inc.	1.23%	3,038,421
24	REGN	Regeneron Pharmaceuticals, Inc.	1.16%	698,374
25	COR	Cencora, Inc.	1.12%	1,329,265

Showing 25 of 63 holdings

Subscribe to see the full list

Upgrade Now

As of Oct 3, 2025